XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED BALANCE SHEETS - USD ($)
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Oct. 30, 2019
Current assets        
Current asset - cash $ 2,955,367   $ 34,000  
Prepaid expenses 398,322   0  
Total Current Assets 3,353,689   34,000  
Deferred offering costs 0   284,930  
Deferred tax asset 1,337   0  
Marketable securities held in Trust Account 1,104,209,313   0  
TOTAL ASSETS 1,107,564,339   318,930  
Current liabilities        
Accrued expenses 1,512,006   1,450  
Accrued offering costs 0   168,930  
Income taxes payable 452,305   0  
Promissory note - related party 0   125,000  
Total Current Liabilities 1,964,311   295,380  
Deferred tax liability 0   0  
Deferred underwriting fee payable 38,500,000   0  
Total Liabilities 40,464,311   295,380  
Commitments    
Common stock subject to possible redemption, 000 and no shares at redemption value at September 30, 2020 and December 31, 2019, respectively 1,062,100,027   0  
Stockholders' Equity        
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 0   0  
Additional paid-in capital 3,301,789   22,250  
Accumulated deficit 1,695,048   (1,450)  
Total Stockholders' Equity 5,000,001 $ 5,000,007 23,550 $ 0
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 1,107,564,339   318,930  
Class A Common Stock        
Stockholders' Equity        
Common stock value 414   0  
Total Stockholders' Equity 414 401 0  
Class B Common Stock        
Stockholders' Equity        
Common stock value [1] 2,750   2,750 [2]  
Total Stockholders' Equity $ 2,750 $ 2,750 $ 2,750  
[1] Included an aggregate of 2,500,000 shares that were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full at December 31, 2019 (see Note 5).
[2] Excludes an aggregate of 2,500,000 shares that are subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full (see Notes 7 and 8).